Classification Term: 1865
Macrolactams (ontology term: CHEMONTID:0000064)
Cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring. They are nitrogen analogues (the a nitrogen atom replacing the o atom of the cyclic carboxylic acid group ) of the naturally occurring macrolides." []
found 28 associated metabolites at class
metabolite taxonomy ontology rank level.
Ancestor: Phenylpropanoids and polyketides
Child Taxonomies: There is no child term of current ontology term.
Rifaximin
Rifaximin is only found in individuals that have used or taken this drug. It is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that the drug will not pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics. It is used to treat diarrhea caused by E. coli.Rifaximin acts by inhibiting RNA synthesis in susceptible bacteria by binding to the beta-subunit of bacterial deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase enzyme. This results in the blockage of the translocation step that normally follows the formation of the first phosphodiester bond, which occurs in the transcription process. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins D005765 - Gastrointestinal Agents
Rifabutin
Rifabutin is only found in individuals that have used or taken this drug. It is a broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients. [PubChem]Rifabutin acts via the inhibition of DNA-dependent RNA polymerase in gram-positive and some gram-negative bacteria, leading to a suppression of RNA synthesis and cell death.
17-AAG
17-Dimethylaminogeldanamycin
25-Desacetyl rifapentine
25-Desacetylrifampicin
Ravtansine
C38H54ClN3O10S (779.3218254000001)
Ansamitocin P-3
N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide
C30H43N3O6S (573.2872418000001)
geldanamycin
herbimycin a
25-O-Deacetylrifabutin
Lorlatinib
Macrocycle
Maitansine
Maytansinoid DM4
C39H56ClN3O10S (793.3374746000001)
Mertansine
Palustrine
Retaspimycin
Rifametane
Rifampicin
Rifamycins
Rifapentina
Ruboxistaurin
Olysio
C38H47N5O7S2 (749.2916752000001)
Soravtansine
C42H60ClN3O15S3 (977.2874919999999)